Lower riskMedical device recall · FDA · Published July 26, 2022
Medtronic Vanta Clinician Programmer App v2.0.2455 may show error 1502 preventing
Medtronic recalls Vanta Clinician Programmer App version 2.0.2455 for pain therapy devices that may show error 1502, preventing programming of implantable neurostimulators.
Potential for Vanta Clinician Programmer Application (CP App) A71200 v2.0.2455 to display an Unexpected Device Error Code 1502 Message, and the user will be unable to perform programming of the Vanta Implantable Neurostimulator (INS) Model 977006.
Take action
Contact the company
📍Recalling firmMedtronic Neuromodulation7000 Central Ave Ne · Minneapolis, MN 55432-3568
✎ GovInfoNow plain-language explainer
Medtronic is recalling its Vanta Clinician Programmer Application software version 2.0.2455 for pain therapy devices. This version may display an error message that prevents users from programming their implantable neurostimulators, which could lead to improper device settings. Read more at govinfonow.com/recall/60311-medtronic-vanta-clinician-programmer-app-v2-0-2455-may-show.
“Medtronic Vanta Clinician Programmer App v2.0.2455 may show error 1502 preventing.” GovInfoNow, updated August 19, 2026. https://govinfonow.com/recall/60311-medtronic-vanta-clinician-programmer-app-v2-0-2455-may-show. Based on FDA recall #Z-1571-2022 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1571-2022%22&limit=1).
The FDA announced on July 26, 2022, that Medtronic Neuromodulation is recalling the Vanta Clinician Programmer Application, Model A71200. The software may display an unexpected error code preventing programming of the Vanta Implantable Neurostimulator.
How to tell if you have it
Medtronic Neuromodulation Vanta Clinician Programmer Application, Model A71200
Software Version 2.0.2455
The hazard
The Vanta Clinician Programmer Application (CP App) A71200 v2.0.2455 may display an Unexpected Device Error Code 1502 Message. This error prevents users from performing programming of the Vanta Implantable Neurostimulator (INS) Model 977006.
Context
GovInfoNow's records show Medtronic Neuromodulation has issued 45 other recalls since August 9, 2017. Other recent recalls of similar products include Medtronic Vanta CP App Software Recall (December 3, 2025) and Medtronic SynchroMed Flex Infusion Software Issue (April 8, 2026).
How to tell if you have this one
Check if you have the Vanta Clinician Programmer Application software version 2.0.2455 for Medtronic Model 977006 Vanta implantable neurostimulators used in pain therapy.
Brand
Medtronic Neuromodulation
Category
Medical device
Based on the official FDA remedy
What to do — step by step
Update Software
Download the updated software version from Medtronic's website to fix the error message issue.
Where it went and when
Where it was distributed
Distributed nationwide and abroad; the notice names 47 states.
Named in the notice
Covered by “nationwide”
Not listed
FDA distribution: “Worldwide distribution - US Nationwide distribution including in the states of AK, AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, SC,…” States read from FDA’s own wording; “not listed” means the notice does not name it.
Named in the notice: Alabama, Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, District of Columbia, Florida, Georgia, Hawaii, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Puerto Rico, South Carolina, South Dakota, Tennessee, Texas, Utah, Virginia, Washington, West Virginia, Wisconsin.
Recall timeline
FDA published this recall 36 days after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #Z-1571-2022 (July 26, 2022) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-1571-2022 to see it in context.
Plain-language summary written by qwen3:4b on August 19, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.